NCD

NCD, colleagues remember Andrés Gallegos

Retrieved on: 
Monday, December 4, 2023

WASHINGTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) has lost its Chairman Andrés J. Gallegos, 62, of Illinois, who passed away Dec. 1.

Key Points: 
  • WASHINGTON, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The National Council on Disability (NCD) has lost its Chairman Andrés J. Gallegos, 62, of Illinois, who passed away Dec. 1.
  • On January 20, 2021, President Biden designated Gallegos Chairman of NCD shortly after being inaugurated President of the United States.
  • Since Gallegos was appointed to the Council in 2018, NCD released 31 reports and papers--15 while chair--making systemic recommendations to improve national disability policy.
  • Chicagoan Andrés Gallegos devoted his life to inclusion, health equity and accessibility.

Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves – Hagens Berman

Retrieved on: 
Tuesday, November 21, 2023

SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .
  • On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.
  • This news drove the price of Silk Medical shares down nearly 50% on Oct. 11, 2023.
  • “We’re focused on investors’ losses and investigating whether Silk Road may have misled investors about the effect of the NCD’s decision on TCAR-related revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.

Silk Road Medical (SILK) Investors with Substantial Losses Encouraged to Contact Hagens Berman, National Trial Attorneys: Firm Investigating Possible Securities Law Violations

Retrieved on: 
Monday, November 13, 2023

On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.

Key Points: 
  • On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.
  • “We’re focused on investors’ losses and investigating whether Silk Road may have misled investors about the effect of the NCD’s decision on TCAR-related revenues,” said Reed Kathrein, the Hagens Berman partner leading the investigation.
  • If you invested in Silk Road Medical and have significant losses, or have knowledge that may assist the firm’s investigation, click here to discuss your legal rights with Hagens Berman .
  • Whistleblowers: Persons with non-public information regarding Silk Road Medical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.

The Bahamas’ National Health Insurance Authority and eClinicalWorks Report Significant Progress with Electronic Health Records

Retrieved on: 
Thursday, December 14, 2023

The National Health Insurance Authority (NHIA) has seen significant progress since the launch of its Electronic Health Record (EHR) system.

Key Points: 
  • The National Health Insurance Authority (NHIA) has seen significant progress since the launch of its Electronic Health Record (EHR) system.
  • The NHIA has partnered with eClinicalWorks , the largest ambulatory cloud EHR and provider of digital healthcare solutions to transform healthcare delivery, and has adopted population health tools that help to analyze population health.
  • With over 150,000 residents enrolled in the NHI Bahamas program, the EHR system aims to enhance patient care, improve operational efficiency, and drive positive health outcomes.
  • “By implementing eClinicalWorks EHR and population health tools, the NHIA is better equipped to track compliance data and improve long-term patient care.”

$420+ Mn ELISpot and FluoroSpot Assay Market - Global Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023

The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "ELISpot and FluoroSpot Assay Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global ELISpot and FluoroSpot Assays Market is expected to reach USD 421 million by 2028 from USD 292 million in 2023, at a CAGR of 7.6%
    This report studies the ELISpot and FluoroSpot Assays market based on product, applications, End user, and region.
  • The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total ELISpot and FluoroSpot Assays market.
  • The Assay kits accounted for the largest market share in the ELISpot and FluoroSpot Assays product' smarket, during the forecast period
    The ELISpot and FluoroSpot Assay Products market is segmented into Assay kits, Analyzers, and Ancillary Products.

DELFI Diagnostics Supports Proposed Legislation to Allow CMS to Review New Blood-Based Screening Tests for Lung Cancer

Retrieved on: 
Wednesday, December 13, 2023

CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.

Key Points: 
  • CMS currently lacks the authority to cover additional approaches to lung cancer screening, such as blood-based ("liquid biopsy") tests, even though access to more screening options may improve lung cancer screening rates.
  • If passed, this bill would enable CMS to use its national coverage determination (NCD) authority and existing coverage standards to review new lung cancer screening tests as well, expediting reviews of products that would enhance the existing lung cancer screening pathway."
  • The Lung Cancer Screening and Prevention Act would amend title XVIII of the Social Security Act to provide this authority, but does not mandate that CMS either review or cover any new lung cancer screening tests in the Medicare program.
  • The proposed legislation aligns with U.S. President Biden's Cancer Moonshot initiative focused on expanding equitable access to cancer screening and prevention, and could be a catalyst both to increasing lung cancer screening and lowering lung cancer mortality rates – key objectives of Healthy People 2030 .

ARC ANGEL COMMUNICATIONS ANNOUNCES ITS CERTIFICATION AS A DISABILITY OWNED BUSINESS ENTERPRISE

Retrieved on: 
Tuesday, November 7, 2023

MELROSE, Mass., Nov. 7, 2023 /PRNewswire/ -- Arc Angel Communications is pleased to announce it is now a certified disability-owned business enterprise, as part of Disability:IN's Supplier Diversity program.

Key Points: 
  • Arc Angel Communications provides Public Relations and disability consulting services for corporations, government agencies, and institutional organizations.
  • Arc Angel Communications is a duly established Limited Liability Corporation and its corporate headquarters are located just outside of Boston in Melrose.
  • A disability-owned business enterprise is a for profit business that is at least 51% owned, managed and controlled by a person with a disability.
  • "Having the opportunity to now serve the business community with disability inclusion services is a great opportunity and obtaining this DOBE certification from Disability:IN demonstrates to organizations that Arc Angel Communications is ready, willing, and ABLE to work with them," said David D'Arcangelo President & CEO of Arc Angel Communications.

InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update

Retrieved on: 
Monday, November 6, 2023

TEL AVIV, Israel and MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for treatment of carotid artery disease and prevention of stroke today announced financial results and business updates for the third quarter ended September 30, 2023.

Key Points: 
  • Generated CGuard revenue for the third quarter 2023 of $1,556,072, an 8.8 % increase over the same period in 2022.
  • Sold 2,734 CGuard EPS stent systems in the third quarter of 2023, as compared to 2,624 in the third quarter of 2022, an increase of 4.2 %.
  • Total financial income for the third quarter of 2023 was $461,000, an increase of $380,000 or 469% compared to $81,000 for the third quarter of 2022.
  • Management will host a conference call today, Monday, November 6th, at 8:30 AM ET, to review financial results and provide an update on corporate developments.

Federal report examines, urges updates of federal programs’ asset and income limits to assist economic health of Americans with disabilities

Retrieved on: 
Tuesday, October 31, 2023

The 2023 report, Toward Economic Security: The Impact of Income and Asset Limits on People with Disabilities comprehensively examines the impact of asset limits in government-sponsored social safety net programs – some of which haven’t been updated in over 30 years -- on the economic self-sufficiency and financial independence of people with disabilities. Asset limits can prevent lower-income people from building savings and exercising financial autonomy without risking loss of access to necessary public assistance programs.

Key Points: 
  • Asset limits can prevent lower-income people from building savings and exercising financial autonomy without risking loss of access to necessary public assistance programs.
  • “Federal disability policies should be about helping people live independently, get to work, and get out of poverty.
  • The current asset and income limits ensure the opposite.”
    The report examines the implications of asset limits in four areas of public policy – health care, cash benefits provided through Supplemental Security Income (SSI), employment, and asset building and wealth protection.
  • “Current asset and income limits put goals of the Americans with Disabilities Act at odds with each other – independent living at the cost of economic self-sufficiency,” said NCD Chairman Andrés Gallegos.

Hagens Berman- Silk Road Medical (SILK) Stock Tanks After Revenues Lowered and CEO Leaves

Retrieved on: 
Tuesday, October 31, 2023

SAN FRANCISCO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now .
  • On Oct. 10, 2023, Silk Road announced, without explanation, that: (1) its Q3 2023 revenues were expected to be below Q2 revenues; and (2) it significantly reduced its expected FY 2023 revenues.
  • If you invested in Silk Road Medical and have significant losses, or have knowledge that may assist the firm’s investigation, submit your losses now .
  • »
    If you’d like more information and answers to frequently asked questions about the Silk Road Medical investigation, read more »
    Whistleblowers: Persons with non-public information regarding Silk Road Medical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.